Millstone Evans Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Hold
13,586
0.98% 19
2025
Q4
$1.43M Buy
13,586
+791
+6% +$74.3K 0.84% 21
2025
Q3
$1.07M Sell
12,795
-254
-2% -$20.9K 0.68% 23
2025
Q2
$1.03M Buy
13,049
+26
+0.2% +$2.07K 0.7% 26
2025
Q1
$1.17M Sell
13,023
-158
-1% -$14.8K 0.79% 25
2024
Q4
$1.31M Buy
+13,181
New +$1.36M 0.89% 22

Other funds holding MRK

Millstone Evans Group's MRK Position: Q1 2026 in Review

Millstone Evans Group held its Merck (MRK) position steady in Q1 2026 at 13,586 shares worth $1.63M. The position accounts for 0.98% of the portfolio, ranked #19.

Millstone Evans Group first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Millstone Evans Group held 13,586 shares of Merck worth $1.63M as of Q1 2026.
  • Millstone Evans Group left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.98% of Millstone Evans Group's portfolio in Q1 2026, its #19 holding.
  • Millstone Evans Group first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Millstone Evans Group's 13F filing for Q1 2026, filed 30 Apr 2026.